These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
360 related articles for article (PubMed ID: 19890262)
1. Gamma and delta neural oscillations and association with clinical symptoms under subanesthetic ketamine. Hong LE; Summerfelt A; Buchanan RW; O'Donnell P; Thaker GK; Weiler MA; Lahti AC Neuropsychopharmacology; 2010 Feb; 35(3):632-40. PubMed ID: 19890262 [TBL] [Abstract][Full Text] [Related]
6. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Krystal JH; Karper LP; Seibyl JP; Freeman GK; Delaney R; Bremner JD; Heninger GR; Bowers MB; Charney DS Arch Gen Psychiatry; 1994 Mar; 51(3):199-214. PubMed ID: 8122957 [TBL] [Abstract][Full Text] [Related]
7. Glycine attenuates impairments of stimulus-evoked gamma oscillations in the ketamine model of schizophrenia. Haaf M; Curic S; Steinmann S; Rauh J; Leicht G; Mulert C Neuroimage; 2022 May; 251():119004. PubMed ID: 35176492 [TBL] [Abstract][Full Text] [Related]
8. Evidence that Subanesthetic Doses of Ketamine Cause Sustained Disruptions of NMDA and AMPA-Mediated Frontoparietal Connectivity in Humans. Muthukumaraswamy SD; Shaw AD; Jackson LE; Hall J; Moran R; Saxena N J Neurosci; 2015 Aug; 35(33):11694-706. PubMed ID: 26290246 [TBL] [Abstract][Full Text] [Related]
13. A comprehensive analysis of auditory event-related potentials and network oscillations in an NMDA receptor antagonist mouse model using a novel wireless recording technology. Schuelert N; Dorner-Ciossek C; Brendel M; Rosenbrock H Physiol Rep; 2018 Aug; 6(16):e13782. PubMed ID: 30155997 [TBL] [Abstract][Full Text] [Related]
14. Activation of cannabinoid-1 receptors disrupts sensory gating and neuronal oscillation: relevance to schizophrenia. Hajós M; Hoffmann WE; Kocsis B Biol Psychiatry; 2008 Jun; 63(11):1075-83. PubMed ID: 18261715 [TBL] [Abstract][Full Text] [Related]
15. Simultaneous EEG/fMRI recorded during ketamine infusion in patients with major depressive disorder. McMillan R; Sumner R; Forsyth A; Campbell D; Malpas G; Maxwell E; Deng C; Hay J; Ponton R; Sundram F; Muthukumaraswamy S Prog Neuropsychopharmacol Biol Psychiatry; 2020 Apr; 99():109838. PubMed ID: 31843628 [TBL] [Abstract][Full Text] [Related]
16. Excitation of Putative Glutamatergic Neurons in the Rat Parabrachial Nucleus Region Reduces Delta Power during Dexmedetomidine but not Ketamine Anesthesia. Melonakos ED; Siegmann MJ; Rey C; O'Brien C; Nikolaeva KK; Solt K; Nehs CJ Anesthesiology; 2021 Oct; 135(4):633-648. PubMed ID: 34270686 [TBL] [Abstract][Full Text] [Related]
18. Hypericum extract reverses S-ketamine-induced changes in auditory evoked potentials in humans - possible implications for the treatment of schizophrenia. Murck H; Spitznagel H; Ploch M; Seibel K; Schaffler K Biol Psychiatry; 2006 Mar; 59(5):440-5. PubMed ID: 16165104 [TBL] [Abstract][Full Text] [Related]
19. Delta Vs Gamma Auditory Steady State Synchrony in Schizophrenia. Puvvada KC; Summerfelt A; Du X; Krishna N; Kochunov P; Rowland LM; Simon JZ; Hong LE Schizophr Bull; 2018 Feb; 44(2):378-387. PubMed ID: 29036430 [TBL] [Abstract][Full Text] [Related]
20. NMDA Receptor Antagonist Effects on Speech-Related Mismatch Negativity and Its Underlying Oscillatory and Source Activity in Healthy Humans. de la Salle S; Shah D; Choueiry J; Bowers H; McIntosh J; Ilivitsky V; Knott V Front Pharmacol; 2019; 10():455. PubMed ID: 31139075 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]